Asco22 Metastatic Breast Cancer Updates | Lee Schwartzberg, Md | Renown Institute For Cancer

ASCO22 Metastatic Breast Cancer Updates | Lee Schwartzberg, MD | Renown Institute for Cancer

Total Health | Oncology

ASCO22 Metastatic Breast Cancer Updates | Sramila Aithal, MD | US Oncology

Total Health | Oncology

Report Back from ASCO 2024: Latest Updates on Metastatic Breast Cancer (MBC)

SHARE Cancer Support

ASCO22 Metastatic Breast Cancer Updates | Anthony Elias, MD | University of Colorado

Total Health | Oncology

ASCO22 Early Stage Breast Cancer Updates | Aixa Soyano, MD| Moffitt Cancer Center

Total Health | Oncology

Lee S. Schwartzberg, MD, FACP on exciting studies for breast cancer investigational agents

Dr Lee Schwartzberg Reflects on the Approval of the First Immunotherapy Regimen in Breast Cancer

INspired | Beyond the White Coat with Dr. Lee Schwartzberg

Total Health | Oncology

Lee S. Schwartzberg, MD, FACP discussing Paloma 2 study results from ASCO 2016

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. Schwartzberg

Total Health | Oncology

Dr Lee Schwartzberg on Genetic Testing for All Patients Diagnosed With Breast Cancer

Dr Lee Schwartzberg on Updates in Managing Breast Cancer in Older Women

CARG Score Chemotherapy Options ABCSG 18 Trial | Cynthia Ma, MD, PhD | ASCO22 Breast Cancer Updates

Total Health | Oncology

Effectiveness of TDXD vs. Sacituzumab for ER+ Breast Cancer | Jane Meisel, MD | ASCO22 Updates

Total Health | Oncology

Dr Lee Schwartzberg Reflects on the First Year of OneOncology

Lee Schwartzberg, MD | What's Exciting in Breast Cancer at 2018 Best of ASCO St. Louis

Total Health | Oncology

Maintenance w/ ET + ribociclib after 1L chemotherapy in HR+/HER2- metastatic breast cancer

Treatment of Metastatic Breast Cancer With Taxanes

Dr Lee Schwartzberg: How OneOncology Will Help Community Practices Navigate Cancer Care Landscape

Future Directions in Breast Cancer - A Conversation with Lee Schwartzberg